Clinical Trial Update: Study of PRRT in Metastatic, World Health Organization (WHO) Grade 1 or 2, SSTR Positive, GEP-NET Who Are Candidates for Cytoreductive Surgery [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating PRRT in metastatic gastroenteropancreatic neuroendocrine tumors that are SSTR-positive and candidates for cytoreductive surgery; curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroenteropancreatic Neuroendocrine Tumor

Drugs mentioned

• LUTATHERA (Lutetium Lu-177 dotatate)

Snippet

Sponsor: Stanford University | Conditions: Gastroenteropancreatic Neuroendocrine Tumor | Phase 1 | Status: RECRUITING